Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2015-07-28 | anti-eTau humanized IgG4 monoclonal antibody | BMS (USA - NY) | progressive supranuclear palsy |
Granting of the orphan status in the EU |
2015-05-04 | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | Gilead Sciences (USA - CA) | congenital long QT syndrome |
Granting of the orphan status in the US |
2015-05-05 | 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9-xanthen]-3-one (Rose Bengal) | Pfizer (USA - NY) Provectus Biopharmaceutical (USA - TN) | melanoma liver cancers |
Granting of a patent |
2015-05-13 | Bruton's tyrosine kinase (Btk) inhibitor | Acerta Pharma (The Netherlands), now AstraZeneca (UK) | chronic lymphocytic leukemia | Granting of the orphan status in the US |
2015-03-31 | antagonist of the endosomal Toll-like receptors (TLRs) 7, 8, and 9 | Idera Pharmaceuticals (USA - MA) | diffuse large B-cell lymphoma |
Granting of the orphan status in the US |
2015-03-24 | ganaxolone | Marinus Pharmaceuticals (USA - PA) | protocadherin 19 (PCDH19) female epilepsy |
Granting of the orphan status in the US |
2015-03-19 | cladribine | Chord Therapeutics (Switzerland) | neuromyelitis optica, neuromyelitis optica spectrum disorder | Granting of the orphan status in the US |
2015-04-02 | golimumab | Janssen Research & Development, a J&J company (USA - NJ) | polyarticular juvenile idiopathic arthritis in pediatric patients (o through 16 years of age) |
Granting of the orphan status in the US |
2015-04-06 | human insulin (rDNA) | Nutrinia (Israel) | short bowel syndrome |
Granting of the orphan status in the US |
2015-03-30 | dalbavancin | Durata Therapeutics, now Actavis (USA - NJ) | acute osteomyelitis in children (0 through 16 years of age) |
Granting of the orphan status in the US |
2015-05-06 | autologous tumor cells fused with polyethylene glycol to human allogeneic FO-1, DNA plasmid transfected tumor cell line | Sebastiano Gattoni-Celli Med. University of SC- Dept of Radiation Oncology (USA - SC) | glioblastoma |
Granting of the orphan status in the US |
2015-05-05 | humanized monoclonal antibody that targets the a-subunit of the human IL-3 receptor also known as the CD123 antigen | Janssen Research & Development, a J&J company (USA - NJ) | acute myeloid leukemia |
Granting of the orphan status in the US |
2015-03-18 | hydrocortisone modified release capsules | Diurnal Limited (UK) | congenital adrenal hyperplasia | Granting of the orphan status in the US |
2018-02-13 | hydrocortisone oral granules | Diurnal Limited (UK) |
|
Granting of a Market Authorisation in the EU |
2015-04-27 | docosahexaenoic acid | Sancilio (USA - FL) | sickle cell disease |
Granting of the orphan status in the US |
2015-04-06 | doxorubicin | Louis D. Falo, Jr. University of Pittsburgh (USA - PA) | cutaneous T-cell lymphoma |
Granting of the orphan status in the US |
2015-04-07 | eflornithine HCL | Cancer Prevention Pharmaceuticals (USA - AZ) | gastric cancer |
Granting of the orphan status in the US |
2015-08-06 | 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol | GW Pharmaceuticals (UK) | neonatal hypoxic ischemic encephalopathy |
Granting of a Fast Track status |
2015-04-27 | cannabidivarin | GW Pharmaceuticals (UK) | epilepsy |
Granting of a patent |
2015-04-09 | sodium ascorbate and menadione sodium bisulfite | IC-MedTech Corporation (USA - CA) | noninfected painful total joint without mechanical complication |
Granting of the orphan status in the US |
© 2024 Biopharmanalyses - Powered by Samacom+